Expedia Group (NASDAQ:EXPE – Free Report) had its price objective trimmed by Oppenheimer from $235.00 to $230.00 in a ...

Such an advance, leaders agree, would fundamentally transform society. Google CEO Sundar Pichai has repeatedly described AI ...

Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Fueled by DOGE’s tactics, many car buyers -- particularly those who identify as liberal or connected with the Democratic Party, the opposition to Trump’s Republicans -- appear to have begun ratcheting ...

Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...

Oppenheimer Asset Management pointed out that the S&P 500 (SP500) has dipped down to test its 200-day moving average ...

Managing Director - Investments CFP The Summa Group of Oppenheimer & Co. Inc. Asset/Investment Management ...

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at Oppenheimer from a “market ...

Remembering Pat, a good friend from Omaha, Neb.

Oppenheimer lowered the firm’s price target on WhiteHorse Finance (WHF) to $11 from $12 on NAV decline, while keeping a Perform rating on the ...

Director Christopher Nolan's The Odyssey, is gearing up to be his biggest blockbuster yet, as there are many exciting facts ...